Condition (MeSH)
Nephroma, Mesoblastic
ClinicalTrials.gov lists 7 trials for Nephroma, Mesoblastic or a narrower condition beneath it. Children's Oncology Group has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
7 of the 7 trials are tagged with Nephroma, Mesoblastic itself; the rest are tagged with a narrower condition beneath it.
When did Nephroma, Mesoblastic trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2016 | 1 |
| 2015 | 1 |
| 2012 | 1 |
| 2008 | 2 |
| 2007 | 1 |
| 2006 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 7 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Nephroma, Mesoblastic trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 3 | 1 |
| Observational | 4 |
How many Nephroma, Mesoblastic trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Nephroma, Mesoblastic trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Children's Oncology Group | 3 |
| Hoffmann-La Roche | 1 |
| INSYS Therapeutics Inc | 1 |
Which serious adverse events do Nephroma, Mesoblastic trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Death not associated with CTCAE term -- Death NOS | 4 | 1 |
| Abdominal pain | 2 | 1 |
| Cellulitis | 2 | 1 |
| Death not associated with CTCAE term -- Disease progression, NOS | 2 | 1 |
| Malignant neoplasm progression | 2 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Nephroma, Mesoblastic? (2)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. | Urology | 2006 | No |
| Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. | Klinische Padiatrie | 2004 | No |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Congenital mesoblastic nephroma | 2665 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Congenital mesoblastic nephroma | 2665 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.